Evidence map›Paper›PMID 40822985›Full record

ArticleFrontiers in toxicology2025

Case Report: Successful management of severe suicidal lamotrigine overdose-induced status epilepticus with sustained low-efficiency dialysis.

Naoki Kawahara, Hiroki Matsui, Koji Morishita

Abstract readCase Reports
In one paragraph

Article in Frontiers in toxicology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Naoki KawaharaTrauma and Acute Critical Care Centre, Institute of Science Tokyo Hospital, Tokyo, Japan.
Hiroki MatsuiTrauma and Acute Critical Care Centre, Institute of Science Tokyo Hospital, Tokyo, Japan.
Koji MorishitaTrauma and Acute Critical Care Centre, Institute of Science Tokyo Hospital, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Lamotrigine, a common antiepileptic, typically has a favorable safety profile. However, an overdose can lead to severe central nervous system complications, including refractory status epilepticus. The optimal management of severe overdose with refractory status epilepticus remains uncertain, and the role of extracorporeal removal methods, such as blood purification, has not been fully established. Case Description: A 20-year-old female with bipolar disorder presented with altered consciousness and status epilepticus 7 h after ingestion of 4.9 g of lamotrigine. As a case of lamotrigine intoxication, initial management with gastric lavage, activated charcoal, benzodiazepines, and levetiracetam failed to control the seizures, and the patient required continuous midazolam and ventilation. Slow low-efficiency dialysis (SLED) was initiated 18 h after admission. Lamotrigine levels substantially decreased from 33.9 to 13.5 μg/mL within 5 h post-SLED, representing a 60.2% reduction. The patient showed marked neurological improvement, with seizure cessation, allowing for discontinuation of midazolam. She was extubated on day 4 and discharged on day 7 with full recovery. Discussion: This case highlights the successful use of SLED in severe lamotrigine overdose-induced refractory status epilepticus. The correlation among SLED use, reduced lamotrigine levels, and clinical improvement suggests that blood purification may be beneficial in severe toxicity, especially in patients with status epilepticus. This adds to the evidence supporting blood purification for accelerated drug removal and improved outcomes in select severe cases. Prompt recognition of this potentially life-threatening condition and consideration of intensive care, including blood purification, are vital for successful management.

Indexed as

blood purification therapycase reportlamotrigineoverdoseslow low-efficiency dialysis

Identifiers

PMID40822985
PMCPMC12350258

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.